Digital Assets & Stocks

TG Therapeutics (TGTX) is a biopharmaceutical company that has developed an innovative drug, Ublituximab, to treat patients with relapsing forms of multiple sclerosis (RMS). Ublituximab is a monoclonal antibody that…

Myovant Sciences (MYOV) is a biopharmaceutical company that has developed a groundbreaking new drug, Myfembree, to treat women with heavy menstrual bleeding associated with uterine fibroids and endometriosis. Myfembree is…

Phantom Pharmaceuticals (NASDAQ: PHAT) recently announced that its drug, Vonoprazan, has been granted priority review by the U.S. Food and Drug Administration (FDA). Vonoprazan is a novel proton pump inhibitor…

Seagen Inc. (NASDAQ: SGEN) recently announced that its drug, Tucatinib, has been granted priority review by the U.S. Food and Drug Administration (FDA). Tucatinib, which is marketed as Tukysa, is…

Acer Therapeutics’ asset ACER-001 is a potential game-changer in the treatment of Urea Cycle Disorders (UCDs) and Maple Syrup Urine Disease (MSUD). ACER-001 is a taste-masked sodium phenylbutyrate drug that…

Madrigal Pharmaceuticals (MDGL) stock surged on Monday after the company announced positive results from a phase 3 clinical study evaluating its experimental drug resmetirom as a treatment for nonalcoholic steatohepatitis…

Exact Sciences Corp (EXAS) has been a popular stock among investors in recent days due to its surging share price. On Friday, EXAS shares soared 17.3% higher as of 11…

Senseonics Holdings Inc (SENS) is an innovative medical technology company that is focused on developing products to help with diabetes care. The company's lead product, EverSense, is a long-term implantable…

CEI may run like COSM On December 16th 2022, COSM previously Cosmos Holdings did a 1-25 reverse split, for every 25 shares you'll receive 1. COSM also changed their name…

On Friday, December 16, 2022, the decentralized exchange (DEX) platform Raydium, based on the Solana blockchain, suffered a malicious attack that resulted in the attacker gaining control of user funds…